Medicare Spending on Hepatitis C Drugs To Surpass $9B This Year
California Healthline, Monday, November 16, 2015
Medicare spending on breakthrough hepatitis C treatments will increase by nearly twofold this year, surpassing $9 billion, according to data from Medicare's Office of the
Michelle